1-3 of 3
alpha-mannosidosis
Close
Sort by
Journal Articles

High-Exposure, Targeted Daily Busulfan and Fludarabine-Based Conditioning for Children Undergoing Hematopoietic Stem Cell Transplantation for Inherited Metabolic Disorders: Outcomes at a Single Center

Weston P Miller, Melisa Kay Stricherz, PharmD, Cathryn Jennissen, PharmD, Nicole Sando, Jennifer Danielson, Troy Lund, Paul J Orchard
Journal: Blood
Blood (2016) 128 (22): 2191.
https://doi.org/10.1182/blood.V128.22.2191.2191
Published: 2016
Journal Articles

Risk Factors for Graft Failure with Busulfan/Fludarabine-Based Conditioning in Children Undergoing Allogeneic Hematopoietic Cell Transplantation for Nonmalignant Disorders

Benjamin Huang, MD, Christopher C. Dvorak, MD, Justin Wahlstrom, MD, Jimmy Hwang, PhD, Janel R Long-Boyle, PharmD, PhD, Morton Jerome Cowan, MD, Biljana N. Horn, MD
Journal: Blood
Blood (2014) 124 (21): 1155.
https://doi.org/10.1182/blood.V124.21.1155.1155
Published: 2014
Journal Articles

Hematopoietic Stem Cell Transplantation (HSCT) for Benign Indications Using Plasma Depleted Umbilical Cord Blood Units (UCB) That Were Not Depleted of Red Blood Cells.

Joseph Rosenthal, MD, Tang-Her Jaing, M.D., Auayporn Nademanee, M.D., Chatchada Karanes, M.D., Michael Graham, M.D., Lee Lee Chan, M.D., Gretchen Eames, M.D., Ah Moy Tan, M.D., Poh-Lin Tan, M.D., Brian Wang, M.S., Peggy Tseng, Tiffany Chow, Tina Wu, Hai-Peng Lin, M.D., David Gjertson, PhD, Lawrence Petz, M.D., Patrick Tan, M.D., Robert Chow, M.D.
Journal: Blood
Blood (2006) 108 (11): 3151.
https://doi.org/10.1182/blood.V108.11.3151.3151
Published: 2006